点击箭头处“ABBS生物化学与生物物理学报”，关注我们哦
！！
虚 拟 专 刊
免疫治疗作为临床上的一种精准治疗方式，是通过增强或激活机体自身的免疫力，从而识别和攻击肿瘤细胞。近两年来ABBS发表了一系列的综述和研究论文探讨了免疫治疗在肿瘤治疗中的应用和进展，主要涉及TCR-T细胞治疗，DNA损伤应答抑制剂，类器官与细胞模型，肿瘤微环境和免疫反应，肿瘤逃逸，肿瘤细菌免疫治疗，PD-1和PD-L1抑制剂，纳米抗体等领域以及针对不同癌症类型的个体化治疗策略，为未来的研究和临床试验提供新的视角。
The recent advancement of TCR-T cell therapies for cancer treatment
Xiang Zhao, Shuai Shao, Lanxin Hu.
Acta Biochim Biophys Sin 2024, 56: 663 - 674.
Advances in DNA damage response inhibitors in colorectal cancer therapy
Yue Yu, Hang Jia, Tianshuai Zhang, Wei Zhang.
Acta Biochim Biophys Sin 2024, 56: 15 - 22.
Progress in patient-derived liver cancer cell models: a step forward for precision medicine
Zhengtao Zhang, Lijian Hui.
Acta Biochim Biophys Sin 2023, 55: 1707 - 1717.
The Hippo signaling pathway: from multiple signals to the hallmarks of cancers
Ning Zhu, Ruizeng Yang, Xiaodong Wang, Liang Yuan, Xiaoyu Li, Fang Wei, Lei Zhang.
Acta Biochim Biophys Sin 2023, 55: 904 - 913.
Advances in landscape and related therapeutic targets of the prostate tumor microenvironment
Duocai Li, Weidong Xu, Yifan Chang, Yutian Xiao, Yundong He, Shancheng Ren.
Acta Biochim Biophys Sin 2023, 55: 956 - 973.
Immunotherapy in leukaemia
Xingmei Mu, Chumao Chen, Loujie Dong, Zhaowei Kang, Zhixian Sun, Xijie Chen, Junke Zheng, Yaping Zhang.
Acta Biochim Biophys Sin 2023, 55: 974 - 987.
Salmonella typhimurium may support cancer treatment: a review
Zeyu Yang, Ling Zou, Bing Yue, Minwei Hu.
Acta Biochim Biophys Sin 2023, 55: 331 - 342.
Triple kill: DDR inhibitors, radiotherapy and immunotherapy leave cancer cells with no escape
Yuyue Qiu, Xinru Hu, Xiaoping Zeng, Hongmei Wang.
Acta Biochim Biophys Sin 2022, 54: 1569 - 1576.
Functions of non-coding RNAs in regulating cancer drug targets
Binshu Chai, Zhongliang Ma, Xianyi Wang, Linfeng Xu, Yanli Li.
Acta Biochim Biophys Sin 2022, 54: 279 - 291.
S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression
Roujia Wang, Youshan Zhao, Zijuan Li, Juan Guo, Sida Zhao, Luxi Song, Dong Wu, Lan Wang, Chunkang Chang.
Acta Biochim Biophys Sin 2023, 55: 194 - 201.
USP9x promotes CD8 + T-cell dysfunction in association with autophagy inhibition in septic liver injury
Lulu Sheng, Juntao Chen, Yiqing Tong, Yi Zhang, Qiming Feng, Zhenghao Tang.
Acta Biochim Biophys Sin 2022, 54: 1765 - 1774.
Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
Run Huang, Guiqi Zhu, Xiutao Fu, Weiren Liu, Chenyang Tao, Jun Gao, Weifeng Qu, Yuan Fang, Xifei Jiang, Zhenbin Ding, Jian Zhou, Yinghong Shi, Jia Fan, Zheng Tang.
Acta Biochim Biophys Sin 2022, 54: 1694 - 1707.
An improved cell line-derived xenograft humanized mouse model for evaluation of PD-1/PD-L1 blocker BMS202-induced immune responses in colorectal cancer
Pengzhao Shang, Liting Yu, Shucheng Cao, Changying Guo, Wanheng Zhang.
Acta Biochim Biophys Sin 2022, 54: 1497 - 1506.
Identification and characterization of blocking nanobodies against human CD70
Xin Zhang, Chang Liu, Yuan Xie, Qianqian Hu, Yuanyuan Chen, Jiangwei Li.
Acta Biochim Biophys Sin 2022, 54: 1518 - 1527.
Analysis of CMTM6 and CMTM4 expression as potential regulators of the PD-L1 protein and its association with prognosis in glioma cancer
Hui Xue, Bin Qiu, Hao Wang, Ping Jiang, Weiwei Zhang, Lixiang Xue, Junjie Wang.
Acta Biochim Biophys Sin 2022, 54: 1193 - 1196.
THE END
ABBS《生物化学与生物物理学报》，1958年创刊，中国科学院分子细胞科学卓越创新中心（生物化学与细胞生物学研究所）主办，主编丁建平研究员。本刊为完全开放获取（OPEN ACCESS）期刊。出版生物化学、分子生物学、生物物理学的综述、论文和简讯。入选中国科技期刊卓越行动计划梯队期刊类项目。JCR IF为3.7，生物化学与分子生物学领域Q3，生物物理学领域Q2。中科院期刊分区表生物学2区。
审核 徐明华/徐文琳
编辑 寿彩华/郑福军 美工 寿彩华
编辑部 abbs@sibs.ac.cn
